U S PHYSICAL THERAPY INC /NV Selling, General and Administrative Expense
U S PHYSICAL THERAPY INC /NV (USPH) reported Selling, General and Administrative Expense of $19.00 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingGeneralAndAdministrativeExpense · last filed 2026-08-07
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for the quarter ending 2026-06-30 was $19.00M, a 8.75% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for the quarter ending 2026-03-31 was $18.27M, a 12.49% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for the quarter ending 2025-12-31 was $18.13M, a 16.40% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for the quarter ending 2025-09-30 was $17.41M, a 21.06% increase year-over-year.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for fiscal 2025 was $69.26M, a 18.82% increase from fiscal 2024.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for fiscal 2024 was $58.29M, a 12.20% increase from fiscal 2023.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for fiscal 2023 was $51.95M, a 12.67% increase from fiscal 2022.
- U S PHYSICAL THERAPY INC /NV selling, general and administrative expense for fiscal 2022 was $46.11M, a 0.91% decline from fiscal 2021.
| Period end | Selling, General and Administrative Expense 3 month | Selling, General and Administrative Expense 6 month | Selling, General and Administrative Expense 9 month | Selling, General and Administrative Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $19.00M 10-Q · filed 2026-08-07 | $37.28M 10-Q · filed 2026-08-07 | $55.40M derived: sum of 3 quarters · filed 2026-08-07 | $72.82M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $18.27M 10-Q · filed 2026-05-08 | $36.40M derived: sum of 2 quarters · filed 2026-05-08 | $53.81M derived: sum of 3 quarters · filed 2026-05-08 | $71.29M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $18.13M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $35.54M derived: sum of 2 quarters · filed 2026-02-27 | $53.02M derived: sum of 3 quarters · filed 2026-08-07 | $69.26M 10-K · filed 2026-02-27 |
| 2025-09-30 | $17.41M 10-Q · filed 2025-11-07 | $34.89M derived: sum of 2 quarters · filed 2026-08-07 | $51.13M 10-Q · filed 2025-11-07 | $66.71M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $17.48M 10-Q · filed 2026-08-07 | $33.72M 10-Q · filed 2026-08-07 | $49.29M derived: sum of 3 quarters · filed 2026-08-07 | $63.68M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $16.25M 10-Q · filed 2026-05-08 | $31.82M derived: sum of 2 quarters · filed 2026-05-08 | $46.20M derived: sum of 3 quarters · filed 2026-05-08 | $60.45M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $15.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $29.96M derived: sum of 2 quarters · filed 2026-02-27 | $44.20M derived: sum of 3 quarters · filed 2026-02-27 | $58.29M 10-K · filed 2026-02-27 |
| 2024-09-30 | $14.38M 10-Q · filed 2025-11-07 | $28.63M derived: sum of 2 quarters · filed 2025-11-07 | $42.72M 10-Q · filed 2025-11-07 | $56.62M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $14.25M 10-Q · filed 2025-08-08 | $28.33M 10-Q · filed 2025-08-08 | $42.23M derived: sum of 3 quarters · filed 2026-02-27 | $54.28M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $14.09M 10-Q · filed 2025-05-09 | $27.99M derived: sum of 2 quarters · filed 2026-02-27 | $40.03M derived: sum of 3 quarters · filed 2026-02-27 | $52.18M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $13.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.95M derived: sum of 2 quarters · filed 2026-02-27 | $38.09M derived: sum of 3 quarters · filed 2026-02-27 | $51.95M 10-K · filed 2026-02-27 |
| 2023-09-30 | $12.05M 10-Q · filed 2024-11-08 | $24.19M derived: sum of 2 quarters · filed 2024-11-08 | $38.05M 10-Q · filed 2024-11-08 | $49.98M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | $12.14M 10-Q · filed 2024-08-14 | $26.00M 10-Q · filed 2024-08-14 | $37.93M derived: sum of 3 quarters · filed 2025-03-03 | $49.82M derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | $13.86M 10-Q · filed 2024-05-08 | $25.78M derived: sum of 2 quarters · filed 2025-03-03 | $37.67M derived: sum of 3 quarters · filed 2025-03-03 | $48.41M derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | $11.93M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | $23.81M derived: sum of 2 quarters · filed 2025-03-03 | $34.55M derived: sum of 3 quarters · filed 2025-03-03 | $46.11M 10-K · filed 2025-03-03 |
| 2022-09-30 | $11.89M 10-Q · filed 2023-11-08 | $22.63M derived: sum of 2 quarters · filed 2023-11-08 | $34.19M 10-Q · filed 2023-11-08 | $44.90M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $10.74M 10-Q · filed 2023-08-09 | $22.30M 10-Q · filed 2023-08-09 | $33.02M derived: sum of 3 quarters · filed 2024-02-29 | $45.88M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $11.56M 10-Q · filed 2023-05-05 | $22.27M derived: sum of 2 quarters · filed 2024-02-29 | $35.14M derived: sum of 3 quarters · filed 2024-02-29 | $47.22M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $10.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $23.59M derived: sum of 2 quarters · filed 2024-02-29 | $35.66M derived: sum of 3 quarters · filed 2024-02-29 | $46.53M 10-K · filed 2024-02-29 |
| 2021-09-30 | $12.87M 10-Q · filed 2022-11-08 | $24.94M derived: sum of 2 quarters · filed 2022-11-08 | $35.81M 10-Q · filed 2022-11-08 | $46.73M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $12.07M 10-Q · filed 2022-08-08 | $22.95M 10-Q · filed 2022-08-08 | $33.86M derived: sum of 3 quarters · filed 2023-02-28 | $44.29M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $10.87M 10-Q · filed 2022-05-09 | $21.79M derived: sum of 2 quarters · filed 2023-02-28 | $32.21M derived: sum of 3 quarters · filed 2023-02-28 | $41.23M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | $10.92M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $21.34M derived: sum of 2 quarters · filed 2023-02-28 | $30.36M derived: sum of 3 quarters · filed 2023-02-28 | $42.04M 10-K · filed 2023-02-28 |
| 2020-09-30 | $10.42M 10-Q · filed 2021-11-09 | $19.44M derived: sum of 2 quarters · filed 2021-11-09 | $31.12M 10-Q · filed 2021-11-09 | $42.79M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $9.02M 10-Q · filed 2021-08-09 | $20.70M 10-Q · filed 2021-08-09 | $32.37M derived: sum of 3 quarters · filed 2022-03-01 | $42.93M derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $11.68M 10-Q · filed 2021-05-10 | $23.35M derived: sum of 2 quarters · filed 2022-03-01 | $33.91M derived: sum of 3 quarters · filed 2022-03-01 | $45.43M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $11.67M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $22.23M derived: sum of 2 quarters · filed 2022-03-01 | $33.76M derived: sum of 3 quarters · filed 2022-03-01 | $45.05M 10-K · filed 2022-03-01 |
| 2019-09-30 | $10.56M 10-Q · filed 2020-11-06 | $22.08M derived: sum of 2 quarters · filed 2020-11-06 | $33.38M 10-Q · filed 2020-11-06 | $43.79M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $11.53M 10-Q · filed 2020-08-07 | $22.82M 10-Q · filed 2020-08-07 | $33.23M derived: sum of 3 quarters · filed 2021-03-01 | $43.88M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $11.29M 10-Q · filed 2020-05-21 | $21.71M derived: sum of 2 quarters · filed 2021-03-01 | $32.35M derived: sum of 3 quarters · filed 2021-03-01 | $42.48M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $10.41M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $21.06M derived: sum of 2 quarters · filed 2021-03-01 | $31.19M derived: sum of 3 quarters · filed 2021-03-01 | $41.35M 10-K · filed 2021-03-01 |
| 2018-09-30 | $10.64M 10-Q · filed 2019-11-08 | $20.77M derived: sum of 2 quarters · filed 2019-11-08 | $30.93M 10-Q · filed 2019-11-08 | $41.12M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-06-30 | $10.13M 10-Q · filed 2019-08-09 | $20.29M 10-Q · filed 2019-08-09 | $30.47M derived: sum of 3 quarters · filed 2020-02-28 | $38.78M derived: sum of 4 quarters · filed 2020-02-28 |
| 2018-03-31 | $10.16M 10-Q · filed 2019-05-06 | $20.34M derived: sum of 2 quarters · filed 2020-02-28 | $28.65M derived: sum of 3 quarters · filed 2020-02-28 | $37.51M derived: sum of 4 quarters · filed 2020-02-28 |
| 2017-12-31 | $10.18M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-28 | $18.49M derived: sum of 2 quarters · filed 2020-02-28 | $27.34M derived: sum of 3 quarters · filed 2020-02-28 | $35.89M 10-K · filed 2020-02-28 |
| 2017-09-30 | $8.30M 10-Q · filed 2018-11-07 | $17.16M derived: sum of 2 quarters · filed 2018-11-07 | $25.71M 10-Q · filed 2018-11-07 | $33.55M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $8.86M 10-Q · filed 2018-08-07 | $17.40M 10-Q · filed 2018-08-07 | $25.24M derived: sum of 3 quarters · filed 2019-03-18 | $32.85M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $8.55M 10-Q · filed 2018-05-07 | $16.39M derived: sum of 2 quarters · filed 2019-03-18 | $24.00M derived: sum of 3 quarters · filed 2019-03-18 | $32.02M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $7.84M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $15.45M derived: sum of 2 quarters · filed 2019-03-18 | $23.48M derived: sum of 3 quarters · filed 2019-03-18 | $32.48M 10-K · filed 2019-03-18 |
| 2016-09-30 | $7.61M 10-Q · filed 2017-11-07 | $15.64M derived: sum of 2 quarters · filed 2017-11-07 | $24.64M 10-Q · filed 2017-11-07 | $33.53M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-06-30 | $8.03M 10-Q · filed 2017-08-07 | $17.03M 10-Q · filed 2017-08-07 | $25.92M derived: sum of 3 quarters · filed 2018-03-14 | $32.85M derived: sum of 4 quarters · filed 2018-03-14 |
| 2016-03-31 | $9.00M 10-Q · filed 2017-06-29 | $17.90M derived: sum of 2 quarters · filed 2018-03-14 | $24.82M derived: sum of 3 quarters · filed 2018-03-14 | $32.41M derived: sum of 4 quarters · filed 2018-03-14 |
| 2015-12-31 | $8.89M derived: 10-K 12 month − 10-K 9 month · filed 2018-03-14 | $15.82M derived: sum of 2 quarters · filed 2018-03-14 | $23.41M derived: sum of 3 quarters · filed 2018-03-14 | $31.07M 10-K · filed 2018-03-14 |
| 2015-09-30 | $6.92M 10-K · filed 2017-06-07 | $14.52M derived: sum of 2 quarters · filed 2017-06-07 | $22.17M 10-K · filed 2017-06-07 | |
| 2015-06-30 | $7.59M 10-K · filed 2017-06-07 | $15.25M 10-K · filed 2017-06-07 | ||
| 2015-03-31 | $7.66M 10-K · filed 2017-06-07 | |||
| 2014-12-31 | $30.40M 10-K · filed 2017-06-07 | |||
| 2013-12-31 | $25.93M 10-K · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |